Muromachi Chemicals

4885.TPharmaceutical

Key numbers · FY ended 2026-05

Revenue¥7.8bn+17.9% YoY Operating income¥743m+71.9% YoY Net income (owners)¥32m+9.2% YoY Total assets¥6.4bn+20.7% YoY EPS (basic)¥40.58-32.8% YoY

Full financial history and reports →

Stock price4885 · View chart ↗

Open the price chart on TradingView.

Latest filings

Mon, Apr 27 · JST1 filing

17:025% STAKEMuromachi Chemicals · Tetsuro Murayama · 14.89% → 10.01%−4.88pp

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
Tetsuro Murayama	10.01%	—	2026-04-27

Each holder's own ratio from its most recent large-shareholding report.